Variant report
Variant | nsv1056543 |
---|---|
Chromosome Location | chr22:23040138-23255556 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5918)
- CpG islands (count:122)
- Chromatin interactive region (count:479)
- LncRNA region (count:29)
- Mature miRNA region (count: 3)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr22:23062845-23063144 | HepG2 | liver: | n/a | n/a |
2 | ARID3A | chr22:23112680-23113069 | K562 | blood: | n/a | n/a |
3 | ARID3A | chr22:23088195-23088474 | K562 | blood: | n/a | n/a |
4 | ARID3A | chr22:23119431-23119566 | K562 | blood: | n/a | n/a |
5 | ARID3A | chr22:23096142-23096349 | HepG2 | liver: | n/a | n/a |
6 | ARID3A | chr22:23185588-23185620 | K562 | blood: | n/a | n/a |
7 | ARID3A | chr22:23071123-23071265 | K562 | blood: | n/a | n/a |
8 | ARID3A | chr22:23052055-23052419 | K562 | blood: | n/a | n/a |
9 | ARID3A | chr22:23122421-23122441 | K562 | blood: | n/a | n/a |
10 | ARID3A | chr22:23095901-23096393 | K562 | blood: | n/a | n/a |
11 | ARID3A | chr22:23226039-23226556 | K562 | blood: | n/a | n/a |
12 | ARID3A | chr22:23062560-23063183 | K562 | blood: | n/a | n/a |
13 | ARID3A | chr22:23123576-23123779 | K562 | blood: | n/a | n/a |
14 | ARID3A | chr22:23232773-23233217 | K562 | blood: | n/a | n/a |
15 | ATF1 | chr22:23079247-23079496 | K562 | blood: | n/a | n/a |
16 | ATF1 | chr22:23202075-23202247 | K562 | blood: | n/a | n/a |
17 | ATF1 | chr22:23071617-23072206 | K562 | blood: | n/a | n/a |
18 | ATF1 | chr22:23104460-23104637 | K562 | blood: | n/a | n/a |
19 | ATF1 | chr22:23223851-23224186 | K562 | blood: | n/a | n/a |
20 | ATF1 | chr22:23180385-23181176 | K562 | blood: | n/a | n/a |
21 | ATF1 | chr22:23167850-23168098 | K562 | blood: | n/a | n/a |
22 | ATF1 | chr22:23145476-23145970 | K562 | blood: | n/a | n/a |
23 | ATF1 | chr22:23158393-23159026 | K562 | blood: | n/a | n/a |
24 | ATF1 | chr22:23252055-23252437 | K562 | blood: | n/a | n/a |
25 | ATF1 | chr22:23162146-23162529 | K562 | blood: | n/a | n/a |
26 | ATF1 | chr22:23147092-23147291 | K562 | blood: | n/a | n/a |
27 | ATF1 | chr22:23251232-23251667 | K562 | blood: | n/a | n/a |
28 | ATF1 | chr22:23213112-23213543 | K562 | blood: | n/a | n/a |
29 | ATF1 | chr22:23172635-23172845 | K562 | blood: | n/a | n/a |
30 | ATF1 | chr22:23151564-23151800 | K562 | blood: | n/a | n/a |
31 | ATF1 | chr22:23210661-23211009 | K562 | blood: | n/a | n/a |
32 | ATF1 | chr22:23086480-23086640 | K562 | blood: | n/a | n/a |
33 | ATF1 | chr22:23129491-23129501 | K562 | blood: | n/a | n/a |
34 | ATF1 | chr22:23234038-23234184 | K562 | blood: | n/a | n/a |
35 | ATF1 | chr22:23182682-23182828 | K562 | blood: | n/a | n/a |
36 | ATF1 | chr22:23138336-23138394 | K562 | blood: | n/a | n/a |
37 | ATF1 | chr22:23072639-23072759 | K562 | blood: | n/a | n/a |
38 | ATF1 | chr22:23066154-23066203 | K562 | blood: | n/a | n/a |
39 | ATF1 | chr22:23086152-23086162 | K562 | blood: | n/a | n/a |
40 | ATF1 | chr22:23094264-23095307 | K562 | blood: | n/a | n/a |
41 | ATF1 | chr22:23194742-23194752 | K562 | blood: | n/a | n/a |
42 | ATF1 | chr22:23069790-23071225 | K562 | blood: | n/a | n/a |
43 | ATF1 | chr22:23107124-23107149 | K562 | blood: | n/a | n/a |
44 | ATF1 | chr22:23203811-23204540 | K562 | blood: | n/a | n/a |
45 | ATF1 | chr22:23110486-23110686 | K562 | blood: | n/a | n/a |
46 | ATF1 | chr22:23166948-23167148 | K562 | blood: | n/a | n/a |
47 | ATF1 | chr22:23077868-23077944 | K562 | blood: | n/a | n/a |
48 | ATF1 | chr22:23127751-23127938 | K562 | blood: | n/a | n/a |
49 | ATF1 | chr22:23062505-23065315 | K562 | blood: | n/a | n/a |
50 | ATF1 | chr22:23146315-23146329 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:23196862-23196912 | HEEpiC | esophagus: | n/a |
2 | chr22:23196862-23196912 | HL-60 | blood: | n/a |
3 | chr22:23196971-23197021 | NB4 | blood: | n/a |
4 | chr22:23196971-23197021 | HCT-116 | colon: | n/a |
5 | chr22:23196971-23197021 | HUVEC | blood vessel: | n/a |
6 | chr22:23196862-23196912 | T-47D | breast: | n/a |
7 | chr22:23196971-23197021 | U87 | brain: | n/a |
8 | chr22:23196862-23196912 | PrEC | prostate: | n/a |
9 | chr22:23196971-23197021 | HRE | kidney: | n/a |
10 | chr22:23196971-23197021 | H1-hESC | embryonic stem cell: | embryo |
11 | chr22:23196862-23196912 | ovcar-3 | ovarian: | n/a |
12 | chr22:23196971-23197021 | ovcar-3 | ovarian: | n/a |
13 | chr22:23196862-23196912 | HCF | heart: | n/a |
14 | chr22:23196862-23196912 | HepG2 | liver: | n/a |
15 | chr22:23196971-23197021 | PANC-1 | pancreas: | n/a |
16 | chr22:23196862-23196912 | HIPEpiC | eye: | n/a |
17 | chr22:23196862-23196912 | NB4 | blood: | n/a |
18 | chr22:23196862-23196912 | IMR90 | lung: | fetal |
19 | chr22:23196862-23196912 | LNCaP | prostate: | n/a |
20 | chr22:23196862-23196912 | SKMC | muscle: | n/a |
21 | chr22:23196971-23197021 | Hepatocyte | liver: | n/a |
22 | chr22:23196971-23197021 | SK-N-SH | brain: | n/a |
23 | chr22:23196971-23197021 | HRCEpiC | kidney: | n/a |
24 | chr22:23196971-23197021 | GM12891 | blood: | n/a |
25 | chr22:23196971-23197021 | BE2_C | brain: | n/a |
26 | chr22:23196971-23197021 | HL-60 | blood: | n/a |
27 | chr22:23196862-23196912 | HRE | kidney: | n/a |
28 | chr22:23196971-23197021 | PrEC | prostate: | n/a |
29 | chr22:23196862-23196912 | HCPEpiC | choroid plexus: | n/a |
30 | chr22:23196862-23196912 | ECC-1 | luminal epithelium: | n/a |
31 | chr22:23196971-23197021 | HCF | heart: | n/a |
32 | chr22:23196971-23197021 | GM06990 | blood: | n/a |
33 | chr22:23196971-23197021 | Jurkat | blood: | n/a |
34 | chr22:23196862-23196912 | HCM | heart: | n/a |
35 | chr22:23196971-23197021 | LNCaP | prostate: | n/a |
36 | chr22:23196971-23197021 | HEK293 | kidney: | embryo |
37 | chr22:23196862-23196912 | PANC-1 | pancreas: | n/a |
38 | chr22:23196862-23196912 | Hepatocyte | liver: | n/a |
39 | chr22:23196862-23196912 | MCF-7 | breast: | n/a |
40 | chr22:23196971-23197021 | HRPEpiC | eye: | n/a |
41 | chr22:23196971-23197021 | NHDF-neo | bronchial: | n/a |
42 | chr22:23196862-23196912 | GM12892 | blood: | n/a |
43 | chr22:23196971-23197021 | A549 | lung: | n/a |
44 | chr22:23196862-23196912 | H1-hESC | embryonic stem cell: | embryo |
45 | chr22:23196862-23196912 | A549 | lung: | n/a |
46 | chr22:23196971-23197021 | HepG2 | liver: | n/a |
47 | chr22:23196862-23196912 | Jurkat | blood: | n/a |
48 | chr22:23196971-23197021 | ProgFib | skin: | n/a |
49 | chr22:23196971-23197021 | HAEpiC | amniotic membrane: | n/a |
50 | chr22:23196862-23196912 | AoSMC | blood vessel: | n/a |
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:22936334..22937118-chr22:23062451..23063036,3 | K562 | blood: | |
2 | chr22:23190239..23191191-chr22:23300316..23300864,2 | K562 | blood: | |
3 | chr22:23108876..23110628-chr22:23461887..23463461,2 | K562 | blood: | |
4 | chr22:23105617..23107256-chr22:23110516..23112530,3 | K562 | blood: | |
5 | chr22:23150428..23152355-chr22:23226807..23228555,2 | K562 | blood: | |
6 | chr22:23123971..23126580-chr22:23128735..23130931,2 | K562 | blood: | |
7 | chr22:23043268..23044923-chr22:23105017..23107636,2 | K562 | blood: | |
8 | chr22:23219288..23219961-chr22:23301164..23301804,2 | K562 | blood: | |
9 | chr22:23130644..23132267-chr22:23201558..23203139,2 | K562 | blood: | |
10 | chr22:23168657..23170784-chr22:23171805..23174406,4 | K562 | blood: | |
11 | chr22:23062701..23064347-chr22:23112525..23115291,2 | K562 | blood: | |
12 | chr22:23096146..23096820-chr22:23130375..23130912,2 | K562 | blood: | |
13 | chr22:23211841..23214589-chr22:23214813..23217953,3 | K562 | blood: | |
14 | chr22:23052895..23053802-chr22:23090485..23090994,2 | MCF-7 | breast: | |
15 | chr22:23249788..23251920-chr22:23270655..23273406,3 | K562 | blood: | |
16 | chr22:23084114..23086702-chr22:23091006..23093288,3 | K562 | blood: | |
17 | chr22:23086607..23088850-chr22:23208581..23210814,2 | K562 | blood: | |
18 | chr22:23145558..23148585-chr22:23176672..23178832,3 | K562 | blood: | |
19 | chr22:23198020..23198527-chr22:23209390..23209956,2 | K562 | blood: | |
20 | chr22:23158068..23161031-chr22:23161901..23164849,3 | K562 | blood: | |
21 | chr22:23225747..23228051-chr22:23236614..23239071,2 | MCF-7 | breast: | |
22 | chr22:23165215..23167481-chr22:23176988..23179274,2 | K562 | blood: | |
23 | chr22:23130817..23133388-chr22:23167138..23169692,2 | K562 | blood: | |
24 | chr22:23095317..23097513-chr22:23111284..23113837,2 | K562 | blood: | |
25 | chr22:23095736..23096392-chr22:23219351..23220241,3 | MCF-7 | breast: | |
26 | chr22:23074680..23076572-chr22:23098152..23100959,3 | K562 | blood: | |
27 | chr22:23203006..23203931-chr22:23230116..23230981,2 | K562 | blood: | |
28 | chr22:23175812..23179209-chr22:23186134..23188076,3 | K562 | blood: | |
29 | chr22:23096107..23096771-chr22:23104516..23105301,3 | K562 | blood: | |
30 | chr22:23146528..23149689-chr22:23183624..23186463,3 | K562 | blood: | |
31 | chr22:23054239..23055029-chr22:23225832..23226341,2 | K562 | blood: | |
32 | chr22:23146528..23149689-chr22:23183624..23186463,3 | K562 | blood: | |
33 | chr22:23032811..23035891-chr22:23043957..23046051,3 | K562 | blood: | |
34 | chr22:23105617..23107256-chr22:23110516..23112530,3 | K562 | blood: | |
35 | chr22:23192808..23196826-chr22:23225644..23227911,5 | K562 | blood: | |
36 | chr22:23033030..23033767-chr22:23041339..23042090,2 | K562 | blood: | |
37 | chr22:23185728..23186473-chr22:23296561..23297083,2 | K562 | blood: | |
38 | chr22:23034980..23035937-chr22:23110495..23111061,2 | K562 | blood: | |
39 | chr22:23112382..23113353-chr22:23225822..23226588,5 | K562 | blood: | |
40 | chr22:23112482..23113319-chr22:23284645..23285620,4 | K562 | blood: | |
41 | chr22:23221270..23222356-chr22:23297830..23298690,5 | MCF-7 | breast: | |
42 | chr22:23212457..23213190-chr22:23224646..23225546,2 | K562 | blood: | |
43 | chr22:23190267..23191637-chr22:23219306..23220272,3 | MCF-7 | breast: | |
44 | chr22:23153953..23157348-chr22:23159325..23163829,7 | K562 | blood: | |
45 | chr22:23158068..23161031-chr22:23161901..23164849,3 | K562 | blood: | |
46 | chr22:23190337..23191135-chr22:23277615..23278474,2 | K562 | blood: | |
47 | chr22:23112086..23113814-chr22:23188708..23190847,2 | K562 | blood: | |
48 | chr22:23112664..23113297-chr22:23297048..23297785,2 | K562 | blood: | |
49 | chr22:23051984..23054616-chr22:23055450..23057282,2 | MCF-7 | breast: | |
50 | chr22:23130105..23131333-chr22:23284629..23286108,6 | K562 | blood: |
(count:29 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IGLL5-7 | chr22:23157168-23157423 | NONHSAT083824 |
2 | lnc-IGLL5-5 | chr22:23180779-23181049 | NONHSAT083827 |
3 | lnc-POM121L1P-3 | chr22:23053951-23054068 | NONHSAT083813 |
4 | lnc-POM121L1P-5 | chr22:23165262-23165535 | refGeneNc_260_NR_028483 |
5 | lnc-GGTLC2-10 | chr22:23104787-23105009 | NONHSAT083819 |
6 | lnc-GGTLC2-8 | chr22:23081432-23081675 | NONHSAT083816 |
7 | lnc-POM121L1P-1 | chr22:23045057-23045160 | NONHSAT083810 |
8 | lnc-POM121L1P-4 | chr22:23155178-23156344 | ucscGeneNc_uc002zzz_1 |
9 | lnc-RTDR1-4 | chr22:23243305-23243327 | NONHSAT083834 |
10 | lnc-POM121L1P-1 | chr22:23045437-23045463 | NONHSAT083810 |
11 | lnc-RTDR1-4 | chr22:23242926-23243073 | NONHSAT083834 |
12 | lnc-POM121L1P-5 | chr22:23164245-23164726 | refGeneNc_260_NR_028483 |
13 | lnc-POM121L1P-5 | chr22:23197736-23197863 | refGeneNc_260_NR_028483 |
14 | lnc-GGTLC2-7 | chr22:23043245-23043455 | NONHSAT083812 |
15 | lnc-GGTLC2-9 | chr22:23098043-23098286 | NONHSAT083817 |
16 | lnc-RTDR1-1 | chr22:23248506-23248831 | NONHSAT083775 |
17 | lnc-POM121L1P-3 | chr22:23048732-23048890 | NONHSAT083813 |
18 | lnc-POM121L1P-1 | chr22:23045437-23045463 | NONHSAT083808 |
19 | lnc-POM121L1P-1 | chr22:23045057-23045160 | NONHSAT083808 |
20 | lnc-IGLL5-4 | chr22:23192550-23192799 | NONHSAT083828 |
21 | lnc-RTDR1-6 | chr22:23221233-23221684 | NONHSAT083832 |
22 | lnc-POM121L1P-5 | chr22:23186421-23186739 | refGeneNc_260_NR_028483 |
23 | lnc-POM121L1P-5 | chr22:23200951-23201121 | refGeneNc_260_NR_028483 |
24 | lnc-POM121L1P-5 | chr22:23220658-23220783 | refGeneNc_260_NR_028483 |
25 | lnc-POM121L1P-5 | chr22:23178179-23178296 | refGeneNc_260_NR_028483 |
26 | lnc-POM121L1P-5 | chr22:23167960-23168108 | refGeneNc_260_NR_028483 |
27 | lnc-D87017.1-3 | chr22:23252998-23253245 | NONHSAT083835 |
28 | lnc-RTDR1-6 | chr22:23220011-23220059 | NONHSAT083832 |
29 | lnc-RTDR1-4 | chr22:23243491-23243570 | NONHSAT083834 |
miRNA name | Chromosome Location | mirBase accession |
---|---|---|
hsa-miR-650 | chr22:23165285-23165305 | MIMAT0003320 |
hsa-miR-5571-5p | chr22:23228471-23228491 | MIMAT0022257 |
hsa-miR-5571-3p | chr22:23228511-23228529 | MIMAT0022258 |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000264824 | TF binding region |
IGLV3-7 | TF binding region |
ENSG00000207832 | TF binding region |
IGLV4-3 | TF binding region |
IGLJ5 | TF binding region |
IGLV3-13 | TF binding region |
IGLC1 | TF binding region |
IGLV2-5 | TF binding region |
IGLV2-18 | TF binding region |
IGLV3-17 | TF binding region |
IGLJ6 | TF binding region |
IGLVVI-22-1 | TF binding region |
ENSG00000207830 | TF binding region |
IGLV3-12 | TF binding region |
ENSG00000207835 | TF binding region |
IGLJ2 | TF binding region |
IGLV3-15 | TF binding region |
IGLV3-19 | TF binding region |
ENSG00000223999 | TF binding region |
IGLV3-22 | TF binding region |
IGLV2-14 | TF binding region |
IGLVI-20 | TF binding region |
IGLJ1 | TF binding region |
ENSG00000207833 | TF binding region |
MIR650 | TF binding region |
ENSG00000226477 | TF binding region |
IGLV3-2 | TF binding region |
IGLV3-4 | TF binding region |
ENSG00000237127 | TF binding region |
IGLV3-6 | TF binding region |
IGLV3-16 | TF binding region |
ENSG00000264629 | TF binding region |
IGLJ4 | TF binding region |
IGLC4 | TF binding region |
ENSG00000231392 | TF binding region |
IGLV2-23 | TF binding region |
IGLV2-8 | TF binding region |
IGLC5 | TF binding region |
IGLV3-10 | TF binding region |
IGLV2-11 | TF binding region |
IGLL5 | TF binding region |
IGLJ3 | TF binding region |
IGLC3 | TF binding region |
IGLV3-9 | TF binding region |
IGLV3-1 | TF binding region |
IGLV3-21 | TF binding region |
IGLC2 | TF binding region |
ENSG00000264824 | CpG island |
IGLV3-7 | CpG island |
ENSG00000207832 | CpG island |
IGLV4-3 | CpG island |
IGLJ5 | CpG island |
IGLV3-13 | CpG island |
IGLC1 | CpG island |
IGLV2-5 | CpG island |
IGLV2-18 | CpG island |
IGLV3-17 | CpG island |
IGLJ6 | CpG island |
IGLVVI-22-1 | CpG island |
ENSG00000207830 | CpG island |
IGLV3-12 | CpG island |
ENSG00000207835 | CpG island |
IGLJ2 | CpG island |
IGLV3-15 | CpG island |
IGLV3-19 | CpG island |
ENSG00000223999 | CpG island |
IGLV3-22 | CpG island |
IGLV2-14 | CpG island |
IGLVI-20 | CpG island |
IGLJ1 | CpG island |
ENSG00000207833 | CpG island |
MIR650 | CpG island |
ENSG00000226477 | CpG island |
IGLV3-2 | CpG island |
IGLV3-4 | CpG island |
ENSG00000237127 | CpG island |
IGLV3-6 | CpG island |
IGLV3-16 | CpG island |
ENSG00000264629 | CpG island |
IGLJ4 | CpG island |
IGLC4 | CpG island |
ENSG00000231392 | CpG island |
IGLV2-23 | CpG island |
IGLV2-8 | CpG island |
IGLC5 | CpG island |
IGLV3-10 | CpG island |
IGLV2-11 | CpG island |
IGLL5 | CpG island |
IGLJ3 | CpG island |
IGLC3 | CpG island |
IGLV3-9 | CpG island |
IGLV3-1 | CpG island |
IGLV3-21 | CpG island |
IGLC2 | CpG island |
ENSG00000185686 | chromatin interactions |
ENSG00000211675 | chromatin interactions |
ENSG00000253234 | chromatin interactions |
ENSG00000253546 | chromatin interactions |
ENSG00000211672 | chromatin interactions |
ENSG00000207835 | chromatin interactions |
ENSG00000226420 | chromatin interactions |
ENSG00000254029 | chromatin interactions |
ENSG00000211684 | chromatin interactions |
ENSG00000236794 | chromatin interactions |
ENSG00000226595 | chromatin interactions |
ENSG00000264824 | chromatin interactions |
ENSG00000220891 | chromatin interactions |
ENSG00000207836 | chromatin interactions |
ENSG00000211673 | chromatin interactions |
ENSG00000253590 | chromatin interactions |
ENSG00000211682 | chromatin interactions |
ENSG00000223999 | chromatin interactions |
ENSG00000253448 | chromatin interactions |
ENSG00000253786 | chromatin interactions |
ENSG00000211662 | chromatin interactions |
ENSG00000211664 | chromatin interactions |
ENSG00000254030 | chromatin interactions |
ENSG00000211657 | chromatin interactions |
ENSG00000226477 | chromatin interactions |
ENSG00000211681 | chromatin interactions |
ENSG00000253152 | chromatin interactions |
ENSG00000253963 | chromatin interactions |
ENSG00000222037 | chromatin interactions |
ENSG00000231392 | chromatin interactions |
ENSG00000211685 | chromatin interactions |
ENSG00000211663 | chromatin interactions |
ENSG00000211670 | chromatin interactions |
ENSG00000211671 | chromatin interactions |
ENSG00000207832 | chromatin interactions |
ENSG00000254077 | chromatin interactions |
ENSG00000232350 | chromatin interactions |
ENSG00000211666 | chromatin interactions |
ENSG00000187556 | chromatin interactions |
ENSG00000237127 | chromatin interactions |
ENSG00000211674 | chromatin interactions |
ENSG00000264629 | chromatin interactions |
ENSG00000211669 | chromatin interactions |
ENSG00000211678 | chromatin interactions |
ENSG00000211667 | chromatin interactions |
ENSG00000253822 | chromatin interactions |
ENSG00000186716 | chromatin interactions |
ENSG00000211676 | chromatin interactions |
ENSG00000211665 | chromatin interactions |
ENSG00000211679 | chromatin interactions |
ENSG00000211677 | chromatin interactions |
ENSG00000211680 | chromatin interactions |
ENSG00000211655 | chromatin interactions |
ENSG00000254240 | chromatin interactions |
ENSG00000254709 | chromatin interactions |
ING4 | Mature miRNA region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552238434 | chr22:23040139-23040140 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
2 | rs187070773 | chr22:23040178-23040179 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
3 | rs191882817 | chr22:23040184-23040185 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
4 | rs76719155 | chr22:23040188-23040189 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
5 | rs142369106 | chr22:23040192-23040193 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
6 | rs574212217 | chr22:23040193-23040194 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
7 | rs146368157 | chr22:23040200-23040201 | Bivalent Enhancer Enhancers Weak transcription Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
8 | rs553539573 | chr22:23040203-23040204 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
9 | rs182888556 | chr22:23040222-23040223 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
10 | rs545679531 | chr22:23040223-23040224 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
11 | rs565479438 | chr22:23040238-23040239 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
12 | rs187321311 | chr22:23040260-23040261 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
13 | rs544638704 | chr22:23040261-23040262 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
14 | rs191776065 | chr22:23040270-23040271 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 5 gene(s) | Overlapped CNVs | n/a |
15 | rs114792163 | chr22:23040292-23040293 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs546430065 | chr22:23040304-23040305 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs141478005 | chr22:23040317-23040318 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs12170914 | chr22:23040318-23040319 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs552429622 | chr22:23040339-23040340 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs568837866 | chr22:23040353-23040354 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs5996349 | chr22:23040362-23040363 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs150136962 | chr22:23040366-23040367 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs567776885 | chr22:23040370-23040371 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs533646440 | chr22:23040373-23040374 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs553634234 | chr22:23040380-23040381 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs6003229 | chr22:23040389-23040390 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 4 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs112990747 | chr22:23040397-23040398 | Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs138606664 | chr22:23040404-23040405 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
29 | rs141850006 | chr22:23040407-23040408 | Enhancers Weak transcription Active TSS | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
30 | rs576023472 | chr22:23040421-23040422 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs544575455 | chr22:23040427-23040428 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs540190600 | chr22:23040456-23040457 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs12166262 | chr22:23040461-23040462 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs1312 | chr22:23040462-23040463 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs540711319 | chr22:23040476-23040477 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs560413692 | chr22:23040486-23040487 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs12165881 | chr22:23040487-23040488 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs545704522 | chr22:23040496-23040497 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs562411146 | chr22:23040503-23040504 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs186741094 | chr22:23040505-23040506 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs531513520 | chr22:23040516-23040517 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs552011724 | chr22:23040518-23040519 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs547738410 | chr22:23040521-23040522 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs567717187 | chr22:23040530-23040531 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs527337759 | chr22:23040550-23040551 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs547454530 | chr22:23040551-23040552 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs570481874 | chr22:23040553-23040554 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs539188338 | chr22:23040563-23040564 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs558893130 | chr22:23040570-23040571 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs569524182 | chr22:23040571-23040572 | Enhancers Weak transcription Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Schizophrenia | 17504246 | CNVD |
Digeorge syndrome | 18033723 | CNVD |
22q11 deletion syndrome | 17034021 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
22q11 deletion syndrome | 16829213 | CNVD |
Autism | 22067053 | CNVD |
Autism | 19218893 | CNVD |
Biliary cancer | 22067053 | CNVD |
Congenital heart defect | 21390462 | CNVD |
Digeorge syndrome | 16617304 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Obsessive-compulsive disorder | 22067053 | CNVD |
Psychosis | 22067053 | CNVD |
Schizophrenia | 19415332 | CNVD |
Schizophrenia | 20587603 | CNVD |
Shprintzen syndrome | 19443537 | CNVD |
absent pulmonary valve syndrome | 16795129 | CNVD |
language delay | 22067053 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
renal disease | 17924346 | CNVD |
Schizophrenia | 20433910 | CNVD |
22q11 deletion syndrome | 17028864 | CNVD |
Schizophrenia | 16969581 | CNVD |
Non-syndromic sensorineural hearing loss | 17135275 | CNVD |
velo-cardio-facial syndrome | 17135275 | CNVD |
Digeorge syndrome | 18787571 | CNVD |
Autism | 18925931 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
22q11.2 microdeletion syndrome | 21547621 | CNVD |
Congenital heart defect | 21308838 | CNVD |
Digeorge syndrome | 16512914 | CNVD |
Digeorge syndrome | 20954168 | CNVD |
Nuchal translucency | 21837766 | CNVD |
Right aortic arch in the fetus | 17066500 | CNVD |
Shprintzen syndrome | 17117043 | CNVD |
Tetralogy of fallot | 17405110 | CNVD |
Velocardiofacial syndrome | 20140301 | CNVD |
Velocardiofacial syndrome | 16512914 | CNVD |
bone mass and metabolism | 20516202 | CNVD |
choanal atresia | 18209138 | CNVD |
extracardiac malformations | 17086578 | CNVD |
fetal heart defects | 21308838 | CNVD |
parathyroid gland dysfunction | 16793949 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
velopharyngeal insufficiency | 19620585 | CNVD |
Prader-willi syndrome | 20942916 | CNVD |
22q11 deletion syndrome | 17653112 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cat eye syndrome | 21549014 | CNVD |
Digeorge syndrome | 21549014 | CNVD |
22q11.2 microdeletion syndrome | 22051516 | CNVD |
22q11.2 microdeletion syndrome | 18483005 | CNVD |
22q11.2 microdeletion syndrome | 19565140 | CNVD |
22q11.2 microdeletion syndrome | 20396437 | CNVD |
22q11.2 microdeletion syndrome | 21390462 | CNVD |
22q11.2 microdeletion syndrome | 21573985 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 20970697 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Congenital heart defect | 21257016 | CNVD |
Developmental delay | 18414209 | CNVD |
DiGeorge-Velo cardiofacial | 19284877 | CNVD |
Epilepsy | 20970697 | CNVD |
Heart disease | 20551144 | CNVD |
Hughes'' syndrome | 16595601 | CNVD |
Mental retardation | 18414209 | CNVD |
Okamoto syndrome | 19046188 | CNVD |
Primary immunodeficiency | 22566803 | CNVD |
Schizophrenia | 20877625 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Velocardiofacial syndrome | 17556857 | CNVD |
Velocardiofacial syndrome | 20206275 | CNVD |
Velocardiofacial syndrome | 20970697 | CNVD |
delayed speech development | 21274400 | CNVD |
velo-cardio-facial syndrome | 16511839 | CNVD |
velo-cardio-facial syndrome | 21763005 | CNVD |
22q11.2 microdeletion syndrome | 18799940 | CNVD |
Digeorge syndrome | 20877625 | CNVD |
22q11.2 microdeletion syndrome | 18923514 | CNVD |
Congenital heart defect | 22185286 | CNVD |
DiGeorge-Velo cardiofacial | 16773131 | CNVD |
Digeorge syndrome | 20186050 | CNVD |
velo-cardio-facial conotruncal-face syndrome | 20186050 | CNVD |
22q11.2 microdeletion syndrome | 22116936 | CNVD |
Disorders of sex development | 22290220 | CNVD |
22q11.2 duplication syndrome | 18923514 | CNVD |
Autism | 22095694 | CNVD |
Mental retardation | 19951919 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Mental retardation | 16773131 | CNVD |
22q11.2 microdeletion syndrome | 22395003 | CNVD |
22q11.2 microdeletion syndrome | 18691436 | CNVD |
22q11.2 microdeletion syndrome | 18053182 | CNVD |
22q11.2 microdeletion syndrome | 18324686 | CNVD |
22q11.2 microdeletion syndrome | 20074913 | CNVD |
Congenital heart defect | 20802965 | CNVD |
Congenital heart defect | 21134246 | CNVD |
DiGeorge syndrome | 19040613 | CNVD |
DiGeorge-Velo cardiofacial | 18179902 | CNVD |
Digeorge syndrome | 18172682 | CNVD |
Digeorge syndrome | 22470819 | CNVD |
Digeorge syndrome | 21364285 | CNVD |
Neuroendocrine carcinoma | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20069674 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Tetralogy of fallot | 19144126 | CNVD |
Velo-cardio-facial syndrome | 21364285 | CNVD |
Velocardiofacial syndrome | 18788013 | CNVD |
cardiac malformation | 20573211 | CNVD |
cardiac malformation | 18172682 | CNVD |
velo-cardio-facial syndrome | 18636631 | CNVD |
Schizophrenia | 21822266 | CNVD |
synaptic plasticity | 21368174 | CNVD |
Schizophrenia | 18043741 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Autism | 19046189 | CNVD |
DiGeorge-Velo cardiofacial | 19047251 | CNVD |
Hypernasal speech | 21968682 | CNVD |
Mental retardation | 17339581 | CNVD |
diverse phenotype | 16760730 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
DiGeorge-Velo cardiofacial | 17597781 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Schizophrenia | 18806272 | CNVD |
Schizophrenia | 18990708 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Schizophrenia | 20075378 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Emphysema | 19352772 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Disease | 21346257 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 21147756 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Asthma | 21956041 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
22q11.23 microdeletion syndrome | 19193630 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Autism | 20841430 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Ependymoma | 20639864 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Schizophrenia | 17989066 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:23035800-23040200 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
2 | chr22:23037400-23040200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
3 | chr22:23038000-23040200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
4 | chr22:23038200-23045000 | Weak transcription | Right Atrium | heart |
5 | chr22:23039800-23042600 | Enhancers | Primary B cells from peripheral blood | blood |
6 | chr22:23040000-23040200 | Active TSS | GM12878-XiMat | blood |
7 | chr22:23040000-23041400 | Enhancers | Primary B cells from cord blood | blood |
8 | chr22:23040200-23040400 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
9 | chr22:23040200-23040400 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
10 | chr22:23040200-23040400 | Flanking Active TSS | GM12878-XiMat | blood |
11 | chr22:23040200-23041000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
12 | chr22:23040200-23041800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
13 | chr22:23040400-23040600 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
14 | chr22:23040400-23040800 | Active TSS | GM12878-XiMat | blood |
15 | chr22:23040600-23041000 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
16 | chr22:23041000-23044200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
17 | chr22:23041000-23044400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
18 | chr22:23041400-23044800 | Weak transcription | Primary B cells from cord blood | blood |
19 | chr22:23042600-23049000 | Weak transcription | Primary B cells from peripheral blood | blood |
20 | chr22:23043800-23045800 | Enhancers | Fetal Intestine Large | intestine |
21 | chr22:23044200-23046000 | Enhancers | Stomach Mucosa | stomach |
22 | chr22:23044200-23047400 | Enhancers | Foreskin Fibroblast Primary Cells skin02 | Skin |
23 | chr22:23044400-23046000 | Enhancers | Duodenum Mucosa | Duodenum |
24 | chr22:23044400-23046800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
25 | chr22:23044400-23047000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
26 | chr22:23044400-23047200 | Enhancers | Muscle Satellite Cultured Cells | -- |
27 | chr22:23044600-23045400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
28 | chr22:23044800-23045000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
29 | chr22:23044800-23045600 | Enhancers | Primary B cells from cord blood | blood |
30 | chr22:23045000-23045200 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
31 | chr22:23045000-23045400 | Enhancers | Fetal Intestine Small | intestine |
32 | chr22:23045000-23045600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
33 | chr22:23045000-23047400 | Strong transcription | Right Atrium | heart |
34 | chr22:23045200-23047000 | Enhancers | A549 | lung |
35 | chr22:23045600-23046000 | Enhancers | NHDF-Ad | bronchial |
36 | chr22:23045600-23046600 | Enhancers | HSMM | muscle |
37 | chr22:23045600-23046800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
38 | chr22:23045600-23046800 | Weak transcription | Primary B cells from cord blood | blood |
39 | chr22:23045800-23046200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
40 | chr22:23045800-23046600 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
41 | chr22:23045800-23046800 | Weak transcription | Fetal Intestine Large | intestine |
42 | chr22:23046000-23046800 | Enhancers | Liver | Liver |
43 | chr22:23046000-23051000 | Weak transcription | Duodenum Mucosa | Duodenum |
44 | chr22:23046800-23047000 | Enhancers | Fetal Intestine Large | intestine |
45 | chr22:23046800-23047400 | Enhancers | Primary B cells from cord blood | blood |
46 | chr22:23046800-23047400 | Enhancers | GM12878-XiMat | blood |
47 | chr22:23046800-23051600 | Weak transcription | Liver | Liver |
48 | chr22:23047400-23050800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
49 | chr22:23047400-23051600 | Weak transcription | Right Atrium | heart |
50 | chr22:23048800-23049000 | Enhancers | Ovary | ovary |